UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of July 2019.
Commission File Number 001-38496
Canopy Growth Corporation
(Translation of registrant’s name into English)
1 Hershey Drive
Smiths Falls, Ontario
K7A 0A8
(Address of principal executive office)
Indicate
by check mark whether the registrant files or will file annual reports under cover of Form 20-For Form 40-F:
Form 20-F ☐
Form 40-F ☒
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐
Note: Regulation S-T Rule 101(b)(1) only permits the submission in paper of a Form 6-K if submitted solely to provide an attached annual report to security holders.
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐
Note: Regulation S-T Rule 101(b)(7) only permits the submission in paper of a Form 6-K if submitted to furnish a report or other document that the registrant foreign private issuer must furnish and make public under the laws of the jurisdiction in which the registrant is incorporated, domiciled or legally organized (the registrant’s “home country”), or under the rules of the home country exchange on which the registrant’s securities are traded, as long as the report or other document is not a press release, is not required to be and has not been distributed to the registrant’s security holders, and, if discussing a material event, has already been the subject of a Form 6-K submission or other Commission filing on EDGAR.
Exhibit Index
Exhibit No. |
Description | |
Ex. 99.1 | News Release dated July 30, 2019 - Canopy Growth to Announce First Quarter Fiscal 2020 Financial Results | |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
CANOPY GROWTH CORPORATION | |||
By: |
/s/ Phil Shaer |
||
Phil Shaer Chief Legal Officer |
Dated: July 30, 2019
Exhibit 99.1
Canopy Growth to Announce First Quarter Fiscal 2020 Financial Results
SMITHS FALLS, ON, July 30, 2019 /CNW/ - Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (NYSE: CGC) will release its financial results for the first quarter fiscal 2020 ended June 30, 2019 after financial markets close on August 14, 2019.
Canopy Growth to Announce First Quarter Fiscal 2020 Financial Results (CNW Group/Canopy Growth Corporation)
Following the release of its first quarter 2020 financial results, Canopy Growth will host a conference call and audio webcast with Mark Zekulin, CEO and Mike Lee, EVP & CFO at 8:30 AM Eastern Time on August 15, 2019.
Webcast Information
A live audio webcast will be available at:
https://event.on24.com/wcc/r/2051231/A14492AD4B016E74A761B5AF588F79D4
Calling Information
Toll Free Dial-In Number: 1-888-231-8191
International Dial-In Number: (647) 427-7450
Conference ID: 5299923
Replay Information
A replay of the call will be accessible by telephone until 11:59 PM ET on September 15, 2019.
Toll Free Dial-in Number: 1-855-859-2056
Replay Password: 5299923
About Canopy Growth Corporation
Canopy Growth (TSX:WEED, NYSE:CGC) is a world-leading diversified cannabis, hemp and cannabis device company, offering distinct
brands and curated cannabis varieties in dried, oil and Softgel capsule forms, as well as medical devices through Canopy Growth's
subsidiary, Storz & Bickel GMbH & Co. KG. From product and process innovation to market execution, Canopy Growth is driven
by a passion for leadership and a commitment to building a world-class cannabis company one product, site and country at a time.
Canopy Growth has operations in over a dozen countries across five continents.
Canopy Growth's medical division, Spectrum Therapeutics is proudly dedicated to educating healthcare practitioners, conducting robust clinical research, and furthering the public's understanding of cannabis, and has devoted millions of dollars toward cutting edge, commercializable research and IP development. Spectrum Therapeutics sells a range of full-spectrum products using its colour-coded classification Spectrum system as well as single cannabinoid Dronabinol under the brand Bionorica Ethics.
Canopy Growth operates retail stores across Canada under its award-winning Tweed and Tokyo Smoke banners. Tweed is a globally recognized cannabis brand which has built a large and loyal following by focusing on quality products and meaningful customer relationships.
From our historic public listing on the Toronto Stock Exchange and New York Stock Exchange to our continued international expansion, pride in advancing shareholder value through leadership is engrained in all we do at Canopy Growth. Canopy Growth has established partnerships with leading sector names including cannabis icons Snoop Dogg and Seth Rogen, breeding legends DNA Genetics and Green House Seeds, and Fortune 500 alcohol leader Constellation Brands, to name but a few. Canopy Growth operates eleven licensed cannabis production sites with over 4.7 million square feet of production capacity, including over one million square feet of GMP certified production space. For more information visit www.canopygrowth.com
View original content to download multimedia:http://www.prnewswire.com/news-releases/canopy-growth-to-announce-first-quarter-fiscal-2020-financial-results-300892720.html
SOURCE Canopy Growth Corporation
View original content to download multimedia: http://www.newswire.ca/en/releases/archive/July2019/30/c1304.html
%CIK: 0001737927
For further information: Caitlin O'Hara, Media Relations, Caitlin.Ohara@canopygrowth.com, 613-291-3239; Investor Relations, Tyler Burns, Tyler.Burns@canopygrowth.com, 855-558-9333 ext. 122
CO: Canopy Growth Corporation
CNW 07:00e 30-JUL-19
XE7ZUX;;;/'C=\N\PJ29 +\GERF7Q9A19,&\2\=%HMK"UR'1"9,6.EF
M68I24);YM]NDH"0GT@"1M()'5D^/\3[K##=[:QM\6YFX.H9,5LEM$2.W)=Y>
M1&B"PZVXCKI23T\"*<9.UQDR 7"-><(MK[%T#R9;?G-L*<; =?Z[7C]X/\ ]15*J:YU_KM>/W@__452JJ4^!?8M+B9L_P#L
MC>*F B- >VO(
MEUFS8^UCENG.INO:(F7AQF1SIY><)"T$IT=; )WL:UUJF^/]J[I$FWZ/)G3
MF[@YVDE#S@"6U#H"XAE>EGP]7AJB3F\]?P9RCA7A9"R:"BA)44JUZ0!(V/'K-\QLV-_WQG72);X*HDVVK=< !W(5S E/9'JLZ*CR@
M:WH^&JI^_72%:
ZMI;EQQ:HK1<2%I6!S(;"AZ21X$4[3Y;GE)AL(&?,A(3R@
M>9(7AK7_ ,JL]T4!='#7RK>.F X-!Q#%
FMLJ/
MI+4>I/C589_E>1YOELS)\LN\FZW:>L+DRY*MK60 .F@ D 4FHH
MH'C10/&@'&:?KD+]V1/Z*:6V_P#7F?VB?YBF6:?KD+]V1/Z*:6V_]>9_:)_F
M*SH\"+3XF?I;A.;7#-67)&./]HAE_4F,'.59;/\ G3\*F.436;-:H5U=D-0&
M@XA;B#Z3JRE0(2D#J2.IJ+\'.',# +T]YN?1)MSJE
X;1]POYZ8I>D67,3T4X\^M>X;1]POYZ//K7N&T?<+^>F*7I%
MES$]%.//K7N&T?<+^>CSZU[AM'W"_GIBEZ19
X;
M1]POYZ8I>D67,3T4X\^M>X;1]POYZ//K7N&T?<+^>F*7I%ES$]%.//K7N&T?
M<+^>CSZU[AM'W"_GIBEZ19
X;1]POYZ8I>D67,3
MT4X\^M>X;1]POYZ//K7N&T?<+^>F*7I%ES$]%.//K7N&T?<+^>CSZU[AM'W"
M_GIBEZ19
X;1]POYZ8I>D67,3T4X\^M>X;1]POY
MZ//K7N&T?<+^>F*7I%ES$]%.//K7N&T?<+^>CSZU[AM'W"_GIBEZ19
X;1]POYZ8I>D67,,T_7(7[LB?T4TMM_Z\S^T3_,5V
MWNXNW.:)+K;3?*VAI"&D\J4I0D) V?4*ZK?^O,_M$_S%333C!)B3NVT?I'F
M^976*S=%WU7F^SJC*5!>CI"W@OP T/ $>VJYO^&SKKPIM%[OG9+@RD+F*4VO
M2GDJZ(/+KZ0^)HHKP(16'%YW-9)2E9\BH,8<